Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Axes 15 Percent of its Workforce

NEW YORK, March 17 (GenomeWeb News) - Lynx Therapeutics has cut 15 percent of its workforce, the Hayward, Calif.-based company said today.


The layoffs leave the company with 76 employees.


Lynx is commercializing its Massively Parallel Signature Sequencing analysis platform.


Kevin Corcoran, the company's chief executive officer, said Lynx plans to expand new applications for its DNA sequencing services, and continue to develop its gene-expression services.


"We believe we are well-positioned to execute on our strategy, while keeping costs under control," he said in a statement. "We appreciate the contributions made by former employees and offer them our sincere thanks."


The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.